Prolonged use of chlormadinone acetate and risk of intracranial meningioma: A population‐based cohort study
European Journal of Neurology · 2025-01 · 32 (1)
DOI: 10.1111/ene.16505 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Neurology, online erschienen am 06.11.2024. Verfasst von Noémie Roland und 9 weiteren Autor:innen. Beteiligte Einrichtung: EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), S…. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms, Chlormadinone Acetate. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EPI-PHARE.
Abstract (Originalsprache)
Background and Purpose Chlormadinone acetate (CMA) is a synthetic progestin for which cases of intracranial meningioma have been reported following prolonged exposure.
Method
An observational cohort study was conducted based on the French national health data system. Women aged 10‐70 years and who started CMA between 2007 and 2017 were included. Participants were considered to be exposed if they had received a cumulative dose >360 mg of CMA during the first 6 months and very slightly exposed (control group) when they had received a cumulative dose ≤360 mg. The outcome was surgery or radiotherapy for one or more intracranial meningioma(s). Poisson models assessed the relative risk (RR) of meningioma.
Results
In total, 828,499 women were included: 469,976 in the exposed group (mean age 39.1 years, SD 10.1) and 358,523 in the control group (38.3 years, SD 11.0). Surgery or radiotherapy for intracranial meningioma between 2007 and 2017 was recorded for 164 and 104 women in the exposed and control groups, respectively. The incidence of meningioma was 18.5 and 6.8 per 100,000 person‐years for the exposed and control groups respectively (crude RR = 2.7, 95% confidence interval [CI] 2.1–3.5; age‐adjusted RR = 3.1, 95% CI 2.4–4.0). Meningioma incidence reached almost 47 cases/100,000 person‐years in the most exposed group (>8.64 g), giving an age‐adjusted RR of 6.9, 95% CI 5.1–9.2, relative to the control group.
Conclusions
A strong dose–effect relationship was observed between prolonged use of CMA and risk of meningiomas. As with other progestogens, meningiomas associated with CMA are more likely to be found at the base of the skull.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France.
- EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, EA7379, Paris Est Créteil University (UPEC), Créteil, France.
- Department of Neurosurgery, Lariboisière University Hospital, Paris-Cité University, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Department of Medical Gynaecology, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Paris Saclay University, Le Kremlin-Bicêtre, France.
- Biostatistics and Epidemiology Unit, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Paris Cité University, Paris, France.
ORCID-Profile: Noémie Roland, Pierre Nguyen, Anke Neumann, Léa Hoisnard, Thibault Passeri, Lise Duranteau, Joël Coste, Sébastien Froelich, Mahmoud Zureik, Alain Weill
Förderung
- EPI-PHARE
Zitieren
APA
Roland, N., Nguyen, P., Neumann, A., Hoisnard, L., Passeri, T., Duranteau, L., Coste, J., Froelich, S., Zureik, M., & Weill, A. (2025). Prolonged use of chlormadinone acetate and risk of intracranial meningioma: A population‐based cohort study. European Journal of Neurology, 32(1). https://doi.org/10.1111/ene.16505
Vancouver
Roland N, Nguyen P, Neumann A, Hoisnard L, Passeri T, Duranteau L, et al. Prolonged use of chlormadinone acetate and risk of intracranial meningioma: A population‐based cohort study. European Journal of Neurology. 2025;32(1). doi:10.1111/ene.16505
BibTeX
@article{Roland2025,
author = {Roland, Noémie and Nguyen, Pierre and Neumann, Anke and Hoisnard, Léa and Passeri, Thibault and Duranteau, Lise and Coste, Joël and Froelich, Sébastien and Zureik, Mahmoud and Weill, Alain},
title = {Prolonged use of chlormadinone acetate and risk of intracranial meningioma: A population‐based cohort study},
journal = {European Journal of Neurology},
year = {2025},
volume = {32},
number = {1},
doi = {10.1111/ene.16505}
}
EUVIMED